Strengthening Sri Lanka’s Healthcare via Local Pharma Manufacturing 📈

• Strategic Necessity: High import dependence exposes Sri Lanka’s healthcare system to currency volatility, forex constraints, and global supply chain shocks. Domestic production is critical for national healthcare security and maintaining uninterrupted treatment for chronic conditions. • Economic Benefits: Localizing pharmaceutical manufacturing supports skilled employment, builds technical capabilities, conserves foreign exchange reserves, and creates long-term export potential. • Key Focus Areas: • Quality & Regulation: High manufacturing standards, strict regulatory oversight, and traceability are vital to building consumer and medical trust. • Policy Support: Policy stability, tax concessions on inputs, clear regulatory pathways, and aligned procurement systems are required for long-term investments. • Targeted Capability: Manufacturers are expanding capability in essential therapeutic areas to buffer against future global disruptions.